{"transactions":[{"id":881605,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":64699,"kind":"person","name":"Barlow Carrolee","position":1,"cik":"0001745316","reported_name":"Barlow Carrolee","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2026-02-25T21:56:09.000Z","date":"2026-02-24","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":4475,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These restricted stock units will be settled in common stock upon vesting, which will occur on February 19, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These restricted stock units will be settled in common stock upon vesting, which will occur on February 19, 2026."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4475},"source":{"system":"sec-edgar","filing":"0001745316-26-000004","document":"wk-form4_1772056565.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000174531626000004/wk-form4_1772056565.xml","form_type":"4"}},{"id":881604,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":64699,"kind":"person","name":"Barlow Carrolee","position":1,"cik":"0001745316","reported_name":"Barlow Carrolee","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-25T21:56:09.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":4475,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":27045,"source":{"system":"sec-edgar","filing":"0001745316-26-000004","document":"wk-form4_1772056565.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000174531626000004/wk-form4_1772056565.xml","form_type":"4"}},{"id":890351,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":64699,"kind":"person","name":"Barlow Carrolee","position":1,"cik":"0001745316","reported_name":"Barlow Carrolee","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2026-02-20T21:44:28.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":4977,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each option vests on February 18, 2027."}],"balance_after":4977,"derivative":{"exercise_price":50.2,"expiration_date":"2036-02-18","underlying":"Common Stock","underlying_shares":4977},"source":{"system":"sec-edgar","filing":"0001745316-26-000002","document":"wk-form4_1771623865.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000174531626000002/wk-form4_1771623865.xml","form_type":"4"}},{"id":890350,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":64699,"kind":"person","name":"Barlow Carrolee","position":1,"cik":"0001745316","reported_name":"Barlow Carrolee","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2026-02-20T21:44:28.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":2989,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These restricted stock units will be settled in common stock upon vesting, which will occur on February 18, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These restricted stock units will be settled in common stock upon vesting, which will occur on February 18, 2027."}],"balance_after":2989,"derivative":{"underlying":"Common Stock","underlying_shares":2989},"source":{"system":"sec-edgar","filing":"0001745316-26-000002","document":"wk-form4_1771623865.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000174531626000002/wk-form4_1771623865.xml","form_type":"4"}},{"id":1249164,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":64699,"kind":"person","name":"Barlow Carrolee","position":1,"cik":"0001745316","reported_name":"Barlow Carrolee","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-02-24T22:43:13.000Z","date":"2025-02-22","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":5369,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These restricted stock units were settled in common stock upon vesting, which occurred on February 22, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These restricted stock units were settled in common stock upon vesting, which occurred on February 22, 2025."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":5369},"source":{"system":"sec-edgar","filing":"0001628280-25-007461","document":"wk-form4_1740436987.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000162828025007461/wk-form4_1740436987.xml","form_type":"4"}},{"id":1249163,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":64699,"kind":"person","name":"Barlow Carrolee","position":1,"cik":"0001745316","reported_name":"Barlow Carrolee","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-24T22:43:13.000Z","date":"2025-02-22","kind":"grant","planned":false,"acquired":true,"shares":5369,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":22570,"source":{"system":"sec-edgar","filing":"0001628280-25-007461","document":"wk-form4_1740436987.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000162828025007461/wk-form4_1740436987.xml","form_type":"4"}},{"id":1252455,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":64699,"kind":"person","name":"Barlow Carrolee","position":1,"cik":"0001745316","reported_name":"Barlow Carrolee","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2025-02-21T21:47:15.000Z","date":"2025-02-19","kind":"grant","planned":false,"acquired":true,"shares":4475,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These restricted stock units will be settled in common stock upon vesting, which will occur on February 19, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These restricted stock units will be settled in common stock upon vesting, which will occur on February 19, 2026."}],"balance_after":4475,"derivative":{"underlying":"Common Stock","underlying_shares":4475},"source":{"system":"sec-edgar","filing":"0001628280-25-007179","document":"wk-form4_1740174429.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000162828025007179/wk-form4_1740174429.xml","form_type":"4"}},{"id":1252454,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":64699,"kind":"person","name":"Barlow Carrolee","position":1,"cik":"0001745316","reported_name":"Barlow Carrolee","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-02-21T21:47:15.000Z","date":"2025-02-19","kind":"grant","planned":false,"acquired":true,"shares":7296,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests on February 19, 2026."}],"balance_after":7296,"derivative":{"exercise_price":33.52,"expiration_date":"2035-02-19","underlying":"Common Stock","underlying_shares":7296},"source":{"system":"sec-edgar","filing":"0001628280-25-007179","document":"wk-form4_1740174429.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000162828025007179/wk-form4_1740174429.xml","form_type":"4"}},{"id":1615075,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":64699,"kind":"person","name":"Barlow Carrolee","position":1,"cik":"0001745316","reported_name":"Barlow Carrolee","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-02-27T22:04:24.000Z","date":"2024-02-23","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":3886,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These restricted stock units are settled in common stock upon vesting, which occurred on February 23, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These restricted stock units are settled in common stock upon vesting, which occurred on February 23, 2024."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3886},"source":{"system":"sec-edgar","filing":"0001104659-24-028280","document":"tm247055-16_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000110465924028280/tm247055-16_4seq1.xml","form_type":"4"}},{"id":1615074,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":64699,"kind":"person","name":"Barlow Carrolee","position":1,"cik":"0001745316","reported_name":"Barlow Carrolee","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-27T22:04:24.000Z","date":"2024-02-23","kind":"grant","planned":false,"acquired":true,"shares":3886,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":17201,"source":{"system":"sec-edgar","filing":"0001104659-24-028280","document":"tm247055-16_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000110465924028280/tm247055-16_4seq1.xml","form_type":"4"}},{"id":1618898,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":64699,"kind":"person","name":"Barlow Carrolee","position":1,"cik":"0001745316","reported_name":"Barlow Carrolee","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-02-26T22:02:47.000Z","date":"2024-02-22","kind":"grant","planned":false,"acquired":true,"shares":5369,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These restricted stock units will be settled in common stock upon vesting, which will occur on February 22, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These restricted stock units will be settled in common stock upon vesting, which will occur on February 22, 2025."}],"balance_after":5369,"derivative":{"underlying":"Common Stock","underlying_shares":5369},"source":{"system":"sec-edgar","filing":"0001104659-24-027582","document":"tm247055-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000110465924027582/tm247055-6_4seq1.xml","form_type":"4"}},{"id":1618897,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":64699,"kind":"person","name":"Barlow Carrolee","position":1,"cik":"0001745316","reported_name":"Barlow Carrolee","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2024-02-26T22:02:47.000Z","date":"2024-02-22","kind":"grant","planned":false,"acquired":true,"shares":8252,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests on February 22, 2025"}],"balance_after":8252,"derivative":{"exercise_price":27.94,"expiration_date":"2034-02-22","underlying":"Common Stock","underlying_shares":8252},"source":{"system":"sec-edgar","filing":"0001104659-24-027582","document":"tm247055-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000110465924027582/tm247055-6_4seq1.xml","form_type":"4"}},{"id":1989863,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":64699,"kind":"person","name":"Barlow Carrolee","position":1,"cik":"0001745316","reported_name":"Barlow Carrolee","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-02-27T22:01:54.000Z","date":"2023-02-23","kind":"grant","acquired":true,"shares":3886,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These restricted stock units will be settled in common stock upon vesting, which will occur  on February 23, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These restricted stock units will be settled in common stock upon vesting, which will occur  on February 23, 2024."}],"balance_after":3886,"derivative":{"underlying":"Common Stock","underlying_shares":3886},"source":{"system":"sec-edgar","filing":"0001104659-23-026080","document":"tm237737-14_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000110465923026080/tm237737-14_4seq1.xml","form_type":"4"}},{"id":1989862,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":64699,"kind":"person","name":"Barlow Carrolee","position":1,"cik":"0001745316","reported_name":"Barlow Carrolee","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2023-02-27T22:01:54.000Z","date":"2023-02-23","kind":"grant","acquired":true,"shares":6293,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests on February 23, 2024."}],"balance_after":6293,"derivative":{"exercise_price":38.6,"expiration_date":"2033-02-23","underlying":"Common Stock","underlying_shares":6293},"source":{"system":"sec-edgar","filing":"0001104659-23-026080","document":"tm237737-14_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000110465923026080/tm237737-14_4seq1.xml","form_type":"4"}},{"id":1992631,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":64699,"kind":"person","name":"Barlow Carrolee","position":1,"cik":"0001745316","reported_name":"Barlow Carrolee","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-02-24T22:12:25.000Z","date":"2023-02-22","kind":"disposition_to_issuer","acquired":false,"shares":3882,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These restricted stock units were settled in common stock upon vesting, which occurred on February 22, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These restricted stock units were settled in common stock upon vesting, which occurred on February 22, 2023."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3882},"source":{"system":"sec-edgar","filing":"0001104659-23-025377","document":"tm237737-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000110465923025377/tm237737-3_4seq1.xml","form_type":"4"}},{"id":1992630,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":64699,"kind":"person","name":"Barlow Carrolee","position":1,"cik":"0001745316","reported_name":"Barlow Carrolee","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-24T22:12:25.000Z","date":"2023-02-22","kind":"grant","acquired":true,"shares":3882,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":13315,"source":{"system":"sec-edgar","filing":"0001104659-23-025377","document":"tm237737-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000110465923025377/tm237737-3_4seq1.xml","form_type":"4"}},{"id":2374244,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":64699,"kind":"person","name":"Barlow Carrolee","position":1,"cik":"0001745316","reported_name":"Barlow Carrolee","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-02-25T02:24:41.000Z","date":"2022-02-22","kind":"grant","acquired":true,"shares":3882,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These restricted stock units will be settled in common stock upon vesting, such vesting to occur on February 22, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These restricted stock units will be settled in common stock upon vesting, such vesting to occur on February 22, 2023."}],"balance_after":3882,"derivative":{"underlying":"Common Stock","underlying_shares":3882},"source":{"system":"sec-edgar","filing":"0001104659-22-026878","document":"tm227622-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000110465922026878/tm227622-4_4seq1.xml","form_type":"4"}},{"id":2374243,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":64699,"kind":"person","name":"Barlow Carrolee","position":1,"cik":"0001745316","reported_name":"Barlow Carrolee","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2022-02-25T02:24:41.000Z","date":"2022-02-22","kind":"grant","acquired":true,"shares":6847,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6847,"derivative":{"exercise_price":32.2,"exercise_date":"2023-02-22","expiration_date":"2032-02-22","underlying":"Common Stock","underlying_shares":6847},"source":{"system":"sec-edgar","filing":"0001104659-22-026878","document":"tm227622-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000110465922026878/tm227622-4_4seq1.xml","form_type":"4"}},{"id":2377794,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":64699,"kind":"person","name":"Barlow Carrolee","position":1,"cik":"0001745316","reported_name":"Barlow Carrolee","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-02-23T21:19:05.000Z","date":"2022-02-19","kind":"disposition_to_issuer","acquired":false,"shares":4222,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These restricted stock units were settled in common stock upon vesting, which occurred on February 19, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These restricted stock units were settled in common stock upon vesting, which occurred on February 19, 2022."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4222},"source":{"system":"sec-edgar","filing":"0001104659-22-026108","document":"tm227492-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000110465922026108/tm227492-4_4seq1.xml","form_type":"4"}},{"id":2377793,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":64699,"kind":"person","name":"Barlow Carrolee","position":1,"cik":"0001745316","reported_name":"Barlow Carrolee","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-02-23T21:19:05.000Z","date":"2022-02-19","kind":"grant","acquired":true,"shares":4222,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":9433,"source":{"system":"sec-edgar","filing":"0001104659-22-026108","document":"tm227492-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000110465922026108/tm227492-4_4seq1.xml","form_type":"4"}},{"id":2838637,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":64699,"kind":"person","name":"Barlow Carrolee","position":1,"cik":"0001745316","reported_name":"Barlow Carrolee","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-02-23T23:46:01.000Z","date":"2021-02-19","kind":"grant","acquired":true,"shares":4222,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These shares will be settled in common stock upon vesting, such vesting to occur on February 19, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These shares will be settled in common stock upon vesting, such vesting to occur on February 19, 2022."}],"balance_after":4222,"derivative":{"underlying":"Common Stock","underlying_shares":4222},"source":{"system":"sec-edgar","filing":"0001104659-21-026926","document":"tm217706-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000110465921026926/tm217706-1_4seq1.xml","form_type":"4"}},{"id":2838636,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":64699,"kind":"person","name":"Barlow Carrolee","position":1,"cik":"0001745316","reported_name":"Barlow Carrolee","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2021-02-23T23:46:01.000Z","date":"2021-02-19","kind":"grant","acquired":true,"shares":7365,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":7365,"derivative":{"exercise_price":29.61,"exercise_date":"2022-02-19","expiration_date":"2031-02-19","underlying":"Common Stock","underlying_shares":7365},"source":{"system":"sec-edgar","filing":"0001104659-21-026926","document":"tm217706-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000110465921026926/tm217706-1_4seq1.xml","form_type":"4"}},{"id":3248648,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":64699,"kind":"person","name":"Barlow Carrolee","position":1,"cik":"0001745316","reported_name":"Barlow Carrolee","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2020-02-25T22:24:49.000Z","date":"2020-02-21","kind":"grant","acquired":true,"shares":9305,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":9305,"derivative":{"exercise_price":23.99,"exercise_date":"2021-02-21","expiration_date":"2030-02-21","underlying":"Common Stock","underlying_shares":9305},"source":{"system":"sec-edgar","filing":"0001104659-20-024853","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000110465920024853/a4.xml","form_type":"4"}},{"id":3248647,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":64699,"kind":"person","name":"Barlow Carrolee","position":1,"cik":"0001745316","reported_name":"Barlow Carrolee","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-25T22:24:49.000Z","date":"2020-02-21","kind":"grant","acquired":true,"shares":5211,"price":23.99,"value":125011.89,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit component of the annual equity compensation to directors.  These shares will be settled in common stock upon vesting, such vesting to occur on February 21, 2021.  Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."}],"balance_after":5211,"source":{"system":"sec-edgar","filing":"0001104659-20-024853","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000110465920024853/a4.xml","form_type":"4"}},{"id":3631412,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":64699,"kind":"person","name":"Barlow Carrolee","position":1,"cik":"0001745316","reported_name":"Barlow Carrolee","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2019-02-27T00:25:31.000Z","date":"2019-02-22","kind":"grant","acquired":true,"shares":12427,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":12427,"derivative":{"exercise_price":36.75,"exercise_date":"2020-02-22","expiration_date":"2029-02-22","underlying":"Common Stock","underlying_shares":12427},"source":{"system":"sec-edgar","filing":"0001104659-19-010796","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000110465919010796/a4.xml","form_type":"4"}},{"id":3878415,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":64699,"kind":"person","name":"Barlow Carrolee","position":1,"cik":"0001745316","reported_name":"Barlow Carrolee","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2018-07-02T21:52:23.000Z","date":"2018-06-27","kind":"grant","acquired":true,"shares":10213,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in four equal annual installments beginning on June 27, 2019."}],"balance_after":10213,"derivative":{"exercise_price":58.15,"expiration_date":"2028-06-27","underlying":"Common Stock","underlying_shares":10213},"source":{"system":"sec-edgar","filing":"0001104659-18-043597","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000110465918043597/a4.xml","form_type":"4"}}]}